AI Pre-Assessment for Chemotherapy Units

Supporting oncology teams in evaluating patient readiness for treatment.

Before each chemotherapy cycle, physicians must evaluate multiple factors, including patient symptoms, laboratory results, treatment tolerance, and potential adverse effects.

This evaluation is essential but time-consuming, particularly in high-volume oncology day units.

OncoReady is developing AI-supported tools that help structure and pre-assess patient data before treatment decisions are made.

The system supports:

  • structured patient symptom reporting
  • integration of laboratory results and treatment history
  • identification of potential treatment risks
  • triage of patients who require physician evaluation

By assisting with the pre-assessment process, OncoReady helps oncology teams prioritize patients who require direct medical attention while reducing the burden of routine evaluation.

For chemotherapy day units, this can support:

  • improved workflow efficiency
  • reduced physician overload
  • safer and more consistent pre-treatment assessments
  • better scalability as patient numbers increase

OncoReady is intended to support clinical decision-making under physician supervision and within validated clinical workflows.